Delivery Order SPE2DB20D6035-SPE2DB24FD1GT
- Not listed
- This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The $2,561.63 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total completion date of July 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which covers a...
- This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a major procurement agency within the U.S. Department of Defense. The prime contractor, Amerisourcebergen Drug Corp, was awarded a Firm Fixed Price Delivery Order valued at $2,093.83 with a completion date of February 7, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,348.34, is a delivery order with a firm fixed price. There is no set-aside designation, indicating open competition. Amerisourcebergen is the subsidiary of the parent company, Cencora, Inc., which does business as Amerisourcebergen....
- This federal contract award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,037.73 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which enables the company to provide a comprehensive range...
- This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. The contract has a ceiling value of $60,160.90 and an ultimate...
- This federal contract award is a delivery order for Lidocaine 5% patches, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,042.46 firm-fixed-price contract has an ultimate completion date of June 2, 2023. The award is not associated with a set-aside program. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of Lidocaine 5% Patches to support federal government healthcare programs. The $6,216.00 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Lidocaine 5% patches. The $3,853.88 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award is for the delivery of lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $3,608.36, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the federal government. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% patches. The award, valued at $1,104.13, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. The IDC with the DLA Troop Support Medical, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB24FD1GTDelivery Order
This federal contract award is for the delivery of Lidocaine 5% Patch 30S to the Defense Logistics Agency (DLA). The $6,436.63 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen has established itself as a key vendor for federal healthcare programs, particularly within the Department of Defense (DoD) and Department of Veterans Affairs (VA), through its extensive supply chain and distribution capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 12/1/23 |